The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed · Cited by 3,306
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
Self-citationDoxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,845
The biosynthesis and functional role of cardiolipin
Schlame, M., Rua, D., & Greenberg, M. L. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00005-9 · Cited by 810
THE CREATINE-CREATINE PHOSPHATE ENERGY SHUTTLE
Bessman, S. P., & Carpenter, C. L. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.004151 · Cited by 772
Anthracycline-Induced Cardiotoxicity
Shan, K., Lincoff, A. M., & Young, J. B. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00008 · Cited by 749
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
Olson, R. D., & Mushlin, P. S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.13.2210154 · Cited by 690
Anthrazykline in der Krebstherapie: Ein Überblick
Hortobágyi, G. N. (1997) · Drugs · doi:10.2165/00003495-199700544-00003 · Cited by 678
Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity
Ewer, M. S., & Lippman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.827 · Cited by 646
Davies, K. J., & Doroshow, J. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35746-0 · Cited by 631
Mitochondrial creatine kinase in human health and disease
Schlattner, U., Tokarska-Schlattner, M., & Wallimann, T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.09.004 · Cited by 622
Self-citationDoxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms
Wang, S., Konorev, E. A., Kotamraju, S., Joseph, J., Kalivendi, S., & Kalyanaraman, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400944200 · Cited by 611
Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Ingwall, J. S., & Weiss, R. G. (2004) · Circulation Research · doi:10.1161/01.res.0000137170.41939.d9 · Cited by 604
Anthracycline cardiomyopathy monitored by morphologic changes.
Billingham, M. E., Mason, J. W., Bristow, M. R., & Daniels, J. R. (1978) · PubMed · Cited by 586
Role of Oxidative Stress in Myocardial Hypertrophy and Failure
Sawyer, D. B., Siwik, D. A., Xiao, L., Pimentel, D. R., Singh, K., & Colucci, W. S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.1526 · Cited by 571
Myocytes Die by Multiple Mechanisms in Failing Human Hearts
Kostin, S., Pool, L., Elsässer, A., Hein, S., Drexler, H. C. A., Arnon, E., Hayakawa, Y., Zimmermann, R., Bauer, E., Klövekorn, W.-P., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000067471.95890.5c · Cited by 564
Encyclopedia of biological chemistry
(2013) · Choice Reviews Online · doi:10.5860/choice.51-0034 · Cited by 558
The anthracyclines: will we ever find a better doxorubicin?
Weiss, R. B. (1992) · PubMed · Cited by 558
Doroshow, J. H., & Davies, K. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35747-2 · Cited by 540
Mitochondria as a Pharmacological Target
Szewczyk, A., & Wojtczak, L. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.101 · Cited by 538
Energy metabolism in heart failure
Ventura‐Clapier, R., Garnier, A., & Veksler, V. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055095 · Cited by 499
Mitochondrial Targets of Drug Toxicity
Wallace, K. B., & Starkov, A. A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.353 · Cited by 464
Mitochondrial H + Leak and ROS Generation: An Odd Couple
Brookes, P. S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.016 · Cited by 447
Fry, M., & Green, D. E. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69888-1 · Cited by 403
Cardiotoxicity of cytotoxic drugs
Schimmel, K. J. M., Richel, D. J., van den Brink, R. B. A., & Guchelaar, H.-J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.003 · Cited by 391
Doxorubicin‐Induced Cardiac Mitochondrionopathy
Wallace, K. B. (2003) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2003.930301.x · Cited by 389
Beer, M., Seyfarth, T., Sandstede, J., Landschütz, W., Lipke, C., Köstler, H., von Kienlin, M., Harre, K., Hahn, D., & Neubauer, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02160-5 · Cited by 387
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
Zhou, S., Starkov, A. A., Froberg, M. K., Leino, R. L., & Wallace, K. B. (2001) · PubMed · Cited by 314
Adriamycin cardiomyopathy: pathophysiology and prevention
Singal, P. K., Iliskovic, N., Li, T., & Kumar, D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337145 · Cited by 310
Anthracyclines Induce Calpain-dependent Titin Proteolysis and Necrosis in Cardiomyocytes
Lim, C. C., Zuppinger, C., Guo, X., Kuster, G. M., Helmes, M., Eppenberger, H. M., Suter, T. M., Liao, R., & Sawyer, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308033200 · Cited by 304
Self-citationBeyer, K., & Klingenberg, M. (1985) · Biochemistry · doi:10.1021/bi00336a001 · Cited by 301
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Oxygen/Nitrogen Radicals: Cell Injury and Disease · doi:10.1007/978-1-4615-1087-1_13 · Cited by 296
Structure of mitochondrial creatine kinase
Fritz-Wolf, K., Schnyder, T., Wallimann, T., & Kabsch, W. (1996) · Nature · doi:10.1038/381341a0 · Cited by 294
Self-citationDoxorubicin-induced apoptosis: Implications in cardiotoxicity
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015976430790 · Cited by 293
Probucol Protects Against Adriamycin Cardiomyopathy Without Interfering With Its Antitumor Effect
Siveski-Iliskovic, N., Hill, M., Chow, D. A., & Singal, P. K. (1995) · Circulation · doi:10.1161/01.cir.91.1.10 · Cited by 285
McMillin, J. B., & Dowhan, W. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00329-3 · Cited by 266
Siveski-Iliskovic, N., Kaul, N., & Singal, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.6.2829 · Cited by 265
Ito, H., Miller, S. C., Billingham, M. E., Akimoto, H., Torti, S. V., Wade, R., Gahlmann, R., Lyons, G., Kedes, L., & Torti, F. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4275 · Cited by 255
Cardiac system bioenergetics: metabolic basis of the Frank‐Starling law
Saks, V., Dzeja, P., Schlattner, U., Vendelin, M., Terzic, A., & Wallimann, T. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.101444 · Cited by 251
Self-citationFukazawa, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.012 · Cited by 238
Age-Dependent Declines in Proteasome Activity in the Heart
Bulteau, A.-L., Szweda, L. I., & Friguet, B. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2663 · Cited by 237
Nitrosative stress and pharmacological modulation of heart failure
Pacher, P., Schulz, R., Liaudet, L., & Szabó, C. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.003 · Cited by 237
Apoptotic versus autophagic cell death in heart failure
Knaapen, M. W. M., Davies, M. J., De Bie, M., Haven, A. J., Martinet, W., & Kockx, M. M. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00290-5 · Cited by 233
Weinstein, D. M., Mihm, M. J., & Bauer, J. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39082-2 · Cited by 229
Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its Prevention
Horenstein, M. S., Vander Heide, R. S., & L'Ecuyer, T. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3043 · Cited by 228
Lebrecht, D., Setzer, B., Ketelsen, U.-P., Haberstroh, J., & Walker, U. A. (2003) · Circulation · doi:10.1161/01.cir.0000093196.59829.df · Cited by 219
Rossi, A. M., Eppenberger, H. M., Volpe, P., Cotrufo, R., & Wallimann, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34115-8 · Cited by 215
Self-citationRole of iron in anthracycline cardiotoxicity: new tunes for an old song?
MINOTTI, G., CAIRO, G., & MONTI, E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.199 · Cited by 214
TASSANMANGINA, S., CODOREAN, D., METIVIER, M., COSTA, B., HIMBERLIN, C., JOUANNAUD, C., BLAISE, A., ELAERTS, J., & NAZEYROLLAS, P. (2006) · European Journal of Echocardiography · doi:10.1016/j.euje.2005.04.009 · Cited by 213
Kalivendi, S. V., Konorev, E. A., Cunningham, S., Vanamala, S. K., Kaji, E. H., Joseph, J., & Kalyanaraman, B. (2005) · Biochemical Journal · doi:10.1042/bj20050285 · Cited by 205
Tissue variation in the control of oxidative phosphorylation: Implication for mitochondrial diseases
ROSSIGNOL, R., LETELLIER, T., MALGAT, M., ROCHER, C., & MAZAT, J.-P. (2000) · Biochemical Journal · doi:10.1042/bj3470045 · Cited by 202
The cardiotoxicity of anticancer agents.
Hoff, V., Rozencweig, M., & Piccart, M. J. (1982) · PubMed · Cited by 202
Structure of the adriamycin-cardiolipin complex
Goormaghtigh, E., Huart, P., Praet, M., Brasseur, R., & Ruysschaert, J.-M. (1990) · Biophysical Chemistry · doi:10.1016/0301-4622(90)80012-v · Cited by 200
Analyses of the Molecular Mechanism of Adriamycin-Induced Cardiotoxicity
Gille, L., & Nohl, H. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00025-7 · Cited by 197
Preventive Effect of Erythropoietin on Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy
Li, L., Takemura, G., Li, Y., Miyata, S., Esaki, M., Okada, H., Kanamori, H., Khai, N. C., Maruyama, R., Ogino, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.568402 · Cited by 197
Inhibition of the Mitochondrial Permeability Transition by Creatine Kinase Substrates
Dolder, M., Walzel, B., Speer, O., Schlattner, U., & Wallimann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208705200 · Cited by 194
Self-citationStachowiak, O., Dolder, M., Wallimann, T., & Richter, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16694 · Cited by 190
Self-citationOverexpression of Thioredoxin-1 in Transgenic Mice Attenuates Adriamycin-Induced Cardiotoxicity
Shioji, K., Kishimoto, C., Nakamura, H., Masutani, H., Yuan, Z., Oka, S.-I., & Yodoi, J. (2002) · Circulation · doi:10.1161/01.cir.0000027817.55925.b4 · Cited by 189
Pacher, P., Liaudet, L., Bai, P., Virag, L., Mabley, J. G., Haskó, G., & Szabó, C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.862 · Cited by 188
Vyssokikh, M. Y., & Brdiczka, D. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3693 · Cited by 185
Andrieu‐Abadie, N., Jaffrézou, J., Hatem, S., Laurent, G., Levade, T., & Mercadier, J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.12.1501 · Cited by 182
Mitochondria as subcellular targets for clinically useful anthracyclines
Jung, K., & Reszka, R. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00128-4 · Cited by 182
Anthracycline glycoside-membrane interactions
Goormaghtigh, E., & Ruysschaert, J. M. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(84)90013-3 · Cited by 173
Oxidative Stress and Apoptosis in Heart Dysfunction
Kumar, D., Lou, H., & Singal, P. K. (2002) · Herz · doi:10.1007/s00059-002-2430-3 · Cited by 164
Goorin, A. M., Chauvenet, A. R., Perez-Atayde, A. R., Cruz, J., McKone, R., & Lipshultz, S. E. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81668-3 · Cited by 163
Mihm, M. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00307-2 · Cited by 163
Serrano, J., Palmeira, C. M., Kuehl, D. W., & Wallace, K. B. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00011-0 · Cited by 159
Tokarska-Schlattner, M., Zaugg, M., da Silva, R., Lucchinetti, E., SCHAUB, M. C., Wallimann, T., & Schlattner, U. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01057.2004 · Cited by 159
Self-citationThe anthracycline antibiotics: antitumor drugs that alter chromatin structure
Rabbani, A., Finn, R. M., & Ausió, J. (2004) · BioEssays · doi:10.1002/bies.20160 · Cited by 155
Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells
Gosálvez, M., Blanco, M., Hunter, J., et al. (1974) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(74)90044-9 · Cited by 153
Yen, H., Oberley, T. D., Gairola, C. G., Szweda, L. I., & Clair, D. K. S. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1011 · Cited by 151
Marcillat, O., Zhang, Y., & Davies, K. J. A. (1989) · Biochemical Journal · doi:10.1042/bj2590181 · Cited by 149
Fogli, S., Nieri, P., & Breschi, M. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-0724rev · Cited by 149
Goormaghtigh, E., Brasseur, R., & Ruysschaert, J. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91976-3 · Cited by 149
Cardiotoxicity of doxorubicin and other anthracycline derivatives
Jain, D. (2000) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2000.103324 · Cited by 149
Brdiczka, D. G., Beutner, G., Rück, A., Dolder, M., & Wallimann, T. (1998) · BioFactors · doi:10.1002/biof.5520080311 · Cited by 148
Self-citationMolecular Mechanisms of Doxorubicin-induced Cardiomyopathy
Jeyaseelan, R., Poizat, C. I., Wu, H., & Kedes, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5828 · Cited by 147
Cardiolipin is the membrane receptor for mitochondrial creatine phosphokinase.
Müller, M., Moser, R., Cheneval, D., & Carafoli, E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83700-6 · Cited by 142
Doxorubicin-induced cardiomyopathy
(1984) · Reactions Weekly · doi:10.1007/bf03273255 · Cited by 139
Minotti, G., Recalcati, S., Menna, P., Salvatorelli, E., Corna, G., & Cairo, G. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)78025-8 · Cited by 137
Lebrecht, D., Kokkori, A., Ketelsen, U., Setzer, B., & Walker, U. A. (2005) · The Journal of Pathology · doi:10.1002/path.1863 · Cited by 133
Disruption of Mitochondrial Calcium Homeostasis Following Chronic Doxorubicin Administration
Solem, L. E., Henry, T. R., & Wallace, K. B. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1246 · Cited by 131
Beginnings of a signal-transduction pathway for bioenergetic control of cell survival
Hammerman, P. S., Fox, C. J., & Thompson, C. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.09.008 · Cited by 129
Hrelia, S., Fiorentini, D., Maraldi, T., Angeloni, C., Bordoni, A., Biagi, P. L., & Hakim, G. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00612-0 · Cited by 120
Marcillat, O., Zhang, Y., Lin, S. W., & Davies, K. J. A. (1988) · Biochemical Journal · doi:10.1042/bj2540677 · Cited by 120
Dolder, M., Wendt, S., & Wallimann, T. (2001) · Neurosignals · doi:10.1159/000046878 · Cited by 117
Self-citationMihm, M. J., Yu, F., Weinstein, D. M., Reiser, P. J., & Bauer, J. A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704495 · Cited by 115
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy
Lou, H., Danelisen, I., & Singal, P. K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01054.2004 · Cited by 115
Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
Iliskovic, N., & Singal, P. K. (1997) · Europe PMC (PubMed Central) · Cited by 114
Schlattner, U., Forstner, M., Eder, M., Stachowiak, O., Fritz‐Wolf, K., & Wallimann, T. (1998) · PubMed · Cited by 113
Self-citationThe Mechanisms of Fatty Acid-Induced Proton Permeability of the Inner Mitochondrial Membrane
Wojtczak, L., & Wieckowski, M. R. (1999) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1005444322823 · Cited by 112
Octamers of Mitochondrial Creatine Kinase Isoenzymes Differ in Stability and Membrane Binding
Schlattner, U., & Wallimann, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001919200 · Cited by 109
Self-citationSingal, P. K., & Pierce, G. N. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.3.h419 · Cited by 105
Oliveira, P. J., & Wallace, K. B. (2006) · Toxicology · doi:10.1016/j.tox.2005.12.009 · Cited by 105
Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity.
Herman, E., & Ferrans, V. J. (1998) · PubMed · Cited by 104
Transcriptional analysis of doxorubicin-induced cardiotoxicity
Yi, X., Bekeredjian, R., DeFilippis, N. J., Siddiquee, Z., Fernández, E., & Shohet, R. V. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00832.2005 · Cited by 103
Nicolay, K., & KRUIJFF, B. D. (1987) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(87)90236-2 · Cited by 103
Failing energetics in failing hearts
Dzeja, P. P., Redfield, M. M., Burnett, J. C. J., & Terzic, A. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0071-9 · Cited by 101
Response of Doxorubicin-induced Cardiomyopathy to the Current Management Strategy of Heart Failure
Tallaj, J. A., Franco, V., Rayburn, B. K., Pinderski, L. J., Benza, R. L., Pamboukian, S. V., Foley, B. A., & Bourge, R. C. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.12.108 · Cited by 100
Immediate effects of anticancer drugs on mitochondrial oxygen consumption
Souid, A., Tacka, K. A., Galvan, K., & Penefsky, H. S. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00418-0 · Cited by 97
Crystal structure of brain‐type creatine kinase at 1.41 Å resolution
Eder, M., Schlattner, U., Wallimann, T., Becker, A., Kabsch, W., & Fritz‐Wolf, K. (1999) · Protein Science · doi:10.1110/ps.8.11.2258 · Cited by 94
Self-citationAdriamycin cardiotoxicity: Possible pathogenic mechanisms
Azuma, J. (1981) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(81)90281-9 · Cited by 92
Schlattner, U., Forstner, M., Eder, M., Stachowiak, O., Fritz‐Wolf, K., & Wallimann, T. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006851330913 · Cited by 91
Self-citationMechanism of inhibition of mitochondrial enzymatic complex I–III by adriamycin derivatives
Goormaghtigh, E., Huart, P., Brasseur, R., & Ruysschaert, J. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90406-2 · Cited by 89
Hornemann, T., Stolz, M., & Wallimann, T. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.6.1225 · Cited by 88
Self-citationThe interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes
Nicolay, K., Timmers, R. J. M., Spoelstra, E. C., van der Neut, R., Fok, J. J., Huigen, Y. M., Verkleij, A. J., & KRUIJFF, B. D. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90380-8 · Cited by 86
Minireview: Cardiolipins and Mitochondrial Proton-Selective Leakage
Hoch, F. L. (1998) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1020576315771 · Cited by 83
Inhibition of mitochondrial oxidative phosphorylation by adriamycin
Muhammed, H., Ramasarma, T., & Kurup, C. K. R. (1983) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(83)90155-x · Cited by 80
Houba, P. H. J., Boven, E., van der Meulen‐Muileman, I. H., Leenders, R. G. G., Scheeren, J. W., Pinedo, H. M., & Haisma, H. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1640 · Cited by 80
Activation of A3Adenosine Receptor Protects Against Doxorubicin-induced Cardiotoxicity
Shneyvays, V., Mamedova, L. K., Zinman, T., Jacobson, K. A., & Shainberg, A. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1387 · Cited by 76
A molecular approach to the concerted action of kinases involved in energy homoeostasis
Neumann, D., Schlattner, U., & Wallimann, T. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310169 · Cited by 76
Self-citationAdriamycin: Energy metabolism and mitochondrial oxidations in the heart of treated rabbits
Ferrero, M. E., Ferrero, E., Gaja, G., & Bernelli‐Zazzera, A. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90278-1 · Cited by 76
Papadopoulou, L. C., Theophilidis, G., Thomopoulos, G. N., & Tsiftsoglou, A. S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00305-0 · Cited by 75
Speer, O., Bäck, N., Bürklen, T. S., Brdiczka, D. G., Koretsky, A. P., Wallimann, T., & Eriksson, O. (2005) · Biochemical Journal · doi:10.1042/bj20040386 · Cited by 75
Self-citationTokarska-Schlattner, M., Wallimann, T., & Schlattner, U. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.3.516 · Cited by 75
Self-citationDifferential Effects of Peroxynitrite on Human Mitochondrial Creatine Kinase Isoenzymes
Wendt, S., Schlattner, U., & Wallimann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208572200 · Cited by 71
Self-citationEffects of adriamycin on heart mitochondrial function in rested and exercised rats
Ji, L. L., & Mitchell, E. W. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90488-x · Cited by 70
Solem, L. E., & Wallace, K. B. (1993) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1993.1128 · Cited by 69
Oxidant-Induced Iron Signaling in Doxorubicin-Mediated Apoptosis
Kotamraju, S., Kalivendi, S. V., Konorev, E., Chitambar, C. R., Joseph, J., & Kalyanaraman, B. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)78026-x · Cited by 66
Zhou, S., Heller, L. J., & Wallace, K. B. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9230 · Cited by 65
Strategies for prevention of anthracycline cardiotoxicity
Basser, R. L., & Green, M. D. (1993) · Cancer Treatment Reviews · doi:10.1016/0305-7372(93)90027-o · Cited by 63
Interactions of Adriamycin aglycones with mitochondria may mediate Adriamycin cardiotoxicity
Sokolove, P. M. (1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90176-7 · Cited by 62
Koufen, P., Rück, A., Brdiczka, D. G., Wendt, S., Wallimann, T., & Stark, G. (1999) · Biochemical Journal · doi:10.1042/bj3440413 · Cited by 61
Self-citationCytofluorescence detection of adriamycin-mitochondria interactions in isolated, perfused rat heart
Nicolay, K., Fok, J. J., Voorhout, W. F., Post, J. A., & KRUIJFF, B. D. (1986) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(86)90119-9 · Cited by 61
Site-Selective Modification of Hyperreactive Cysteines of Ryanodine Receptor Complex by Quinones
Feng, W., Liu, G., Xia, R., Abramson, J. J., & Pessah, I. N. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23178-3 · Cited by 60
The mitochondrial phosphate carrier reconstituted in liposomes is inhibited by doxorubicin
Cheneval, D., Müller, M., & Carafoli, E. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)80429-3 · Cited by 60
Nahrendorf, M., Streif, J. U. G., Hiller, K., Hu, K., Nordbeck, P., Ritter, O., Sosnovik, D. E., Bauer, L., Neubauer, S., Jakob, P. M., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01038.2005 · Cited by 60
Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture
DeAtley, S. M., Aksenov, M. Y., Aksenova, M. V., Jordan, B., Carney, J. M., & Butterfield, D. A. (1999) · Toxicology · doi:10.1016/s0300-483x(99)00039-6 · Cited by 58
Octamer-dimer Transitions of Mitochondrial Creatine Kinase in Heart Disease
Soboll, S., Brdiczka, D. G., Jahnke, D., Schmidt, A., Schlattner, U., Wendt, S., Wyss, M., & Wallimann, T. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0925 · Cited by 55
Self-citationBlum, H., Balschi, J. A., & Johnson, R. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99218-5 · Cited by 52
Acute Doxorubicin Cardiotoxicity
Pelikan, P. C. D., Weisfeldt, M. L., Jacobus, W. E., Miceli, M. V., Bulkley, B. H., & Gerstenblith, G. (1986) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198609000-00026 · Cited by 49
Effect of adriamycin on electron transport in rat heart, liver, and tumor mitochondria
Bianchi, C. M., Bagnato, A., Paggi, M. G., & Floridi, A. (1987) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(87)90036-0 · Cited by 45
Sayed‐Ahmed, M. M. (2000) · Pharmacological Research · doi:10.1006/phrs.1999.0583 · Cited by 43
Neri, G. C., Neri, B., Bandinelli, M., Tacca, M. D., Danesi, R., & Riccardi, R. (2009) · Oncology · doi:10.1159/000226952 · Cited by 43
REVERSAL OF DOXORUBICIN-INDUCED CARDIAC METABOLIC DAMAGE BYL-CARNITINE
Sayed‐Ahmed, M. M., Shaarawy, S., Shouman, S. A., & Osman, A. M. (1999) · Pharmacological Research · doi:10.1006/phrs.1998.0438 · Cited by 43
Waldner, R., Laschan, C., Lohninger, A., Gessner, M., Tüchler, H., Huemer, M., Spiegel, W., & Karlic, H. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0054-8 · Cited by 41
Nicolay, K., Aue, W. P., Seelig, J., van Echteld, C. J. A., Ruigrok, T. J. C., & KRUIJFF, B. D. (1987) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(87)90234-5 · Cited by 40
Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy
Ye, Y., Wang, C., Zhang, J. J., Cho, Y. K., Gong, G., Murakami, Y., & Bache, R. J. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h376 · Cited by 40
Selective Inhibition of Muscle Gene Expression by Oxidative Stress in Cardiac Cells
Torti, S. V., Akimoto, H., Lin, K., et al. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0681 · Cited by 39
In-vivo and in-vitro mitochondrial membrane damages induced in mice by adriamycin and derivatives
Praet, M., & Ruysschaert, J. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90027-w · Cited by 38
Intramuscular Mechanisms Regulating Fatty Acid Oxidation during Exercise
Winder, W. W. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1928-1_22 · Cited by 37
Demant, E. J. F. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90626-g · Cited by 36
Metabolite Channeling: Creatine Kinase Microcompartments
Schlattner, U., Tokarska-Schlattner, M., & Wallimann, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00283-8 · Cited by 34
Self-citationJoubert, F., Matéo, P., Gillet, B., Beloeil, J. ‐., Mazet, J. L., & Hoerter, J. A. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000009858.41434.fc · Cited by 33
Spindler, M. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00015-4 · Cited by 33
Mitochondrial cytochrome c oxidase as a target site for daunomycin in K-562 cells and heart tissue.
Papadopoulou, L. C., & Tsiftsoglou, A. S. (1993) · PubMed · Cited by 29
New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity
El‐Demerdash, E., Ali, A. A., Sayed‐Ahmed, M. M., & Osman, A. M. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0676-y · Cited by 29
Cheneval, D., Carafoli, E., Powell, G. L., & Marsh, D. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb15225.x · Cited by 29
Electron spin resonance studies on the mechanism of adriamycin-induced heart mitochondrial damages.
Ogura, R., Sugiyama, M., Haramaki, N., & Hidaka, T. (1991) · PubMed · Cited by 29
Iliskovic, N., Li, T., Khaper, N., Palace, V. P., & Singal, P. K. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5763-0_17 · Cited by 27
Miura, T., Muraoka, S., & Ogiso, T. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.1220 · Cited by 26
Role of exercise in rehabilitation of cancer survivors
Braith, R. W. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20354 · Cited by 24
Iliskovic, N., Li, T., Khaper, N., Palace, V. P., & Singal, P. K. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006845120287 · Cited by 24
Robison, T. W., Giri, S. N., & Wilson, D. W. (1989) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570040204 · Cited by 15
Das, T. K., & Mazumdar, S. (2000) · Biophysical Chemistry · doi:10.1016/s0301-4622(00)00158-7 · Cited by 11
Pelikan, P. C. D., Gerstenblith, G., Vandegaer, K., & Jacobus, W. E. (1988) · Experimental Biology and Medicine · doi:10.3181/00379727-188-42699 · Cited by 11
Toleĭkis, A. I., Kal'venas, A. A., Pp, D., Prashkiavichius, A. K., & Iasaĭtis, A. A. (1988) · PubMed · Cited by 9
Naumann, A., Neubauer, S., Kuhlencordt, P., Hu, K., Tian, R., Gaudron, P., & Ertl, G. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0507-2 · Cited by 3
Cited by
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Self-citationŠimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
Ovarian damage from chemotherapy and current approaches to its protection
Spears, N., Lopes, F., Stefansdottir, A., Rossi, V, De Felici, M., Anderson, R. A., & Klinger, F. G. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz027 · Cited by 657
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
Renu, K., V.G., A., P.B., T. P., & Arunachalam, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.043 · Cited by 588
Metadata
- Authors
- Tokarska-Schlattner, M., Zaugg, M., Zuppinger, C., Wallimann, T., & Schlattner, U.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 41
- Issue
- 3
- Pages
- 389-405
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2072140679
- Cited by
- 350
- References
- 163
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.